Clinical Trials

 

Clinical trials now recruiting patients

Translational Biosciences DRAFT logo 3Translational Biosciences, a wholly-owned subsidiary of Medistem Panama is currently recruiting patients for several IRB-approved clinical trials in Panama.


Feasibility Study of Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells in Patients with Refractory Multiple Sclerosis

This trial is no longer recruiting patients

Umbilical Cord Tissue-Derived Mesenchymal Stem Cells for Rheumatoid Arthritis

View trial...

Safety and Feasibility Study of Mesenchymal Trophic Factor (MTF) for Treatment of Osteoarthritis

View trial...

 Safety and Feasibility Study of Autologous Stromal Vascular Fraction (SVF) Cells for Treatment of Osteoarthritis

View trial...

Autologous Adipose Tissue Stromal Vascular Fraction Cells for Rheumatoid Arthritis

View trial...

Open, prospective trial of treatment of autism spectrum disorders (ASD) using intravenous infusion of umbilical cord tissue mesenchymal stem cells

View trial...

Safety and Feasibility Study of Intranasal Mesenchymal Trophic Factor for Treatment of Asthma

View trial...

Clinical Study of Umbilical Cord Tissue Mesenchymal Stem Cells for Treatment of Osteoarthritis

View trial...

Safety and Feasibility Study of Cell Therapy in Treatment of Spinal Cord Injury Patients

View trial...


Clinical trials coming soon...

Feasibility Study of Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells in Patients with Cerebral Palsy

An investigative protocol for CP will be submitted soon to the National Committee for review.

Open, prospective trial of infusion of umbilical cord tissue mesenchymal stem cells for treatment of congestive heart failure

An investigative protocol for heart failure will be submitted soon to the National Committee for review.